Griffith D, Boal M, Rogers T
Department of Surgery, Bristol Royal Hospital for Children, Upper Maudlin Street, Bristol, BS28BJ, UK.
Department of Surgery, Bristol Royal Hospital for Children, Upper Maudlin Street, Bristol, BS28BJ, UK.
J Pediatr Surg. 2018 Apr;53(4):644-646. doi: 10.1016/j.jpedsurg.2017.07.017. Epub 2017 Jul 24.
To assess the evolution in management of children with parapneumonic effusion and empyema in a tertiary referral centre.
We conducted a retrospective case note review of paediatric patients with parapneumonic effusion, pleural effusion and pleural empyema between December 2006 and December 2015. Digital database searches were performed to identify demographic data, referring hospital, radiological and microbiological investigations. Length of stay and morbidity were analysed.
One hundred fifteen patients had 159 interventions over the study period. Fifty-four children were successfully treated with intercostal drainage (ICD) and urokinase fibrinolysis alone. There were 19 primary video assisted thoracoscopic surgeries (VATS) and 12 VATS after initial intercostal drains. Thirty-three children required a thoracotomy, a reduction of 26% from the previous era (p=0.009). The median length of stay was 9days (range 2-54).
Parapneumonic effusion can be successfully treated with intercostal drainage and intrapleural fibrinolytics, but a proportion requires further surgical intervention. In our hospital, increased utilisation of fibrinolysis and VATS occurred with a corresponding decrease in the need for thoracotomy. Patients needing thoracotomy all had severe disease on ultrasound, but ultrasound did not reliably predict failure of fibrinolytic therapy.
III.
评估在一家三级转诊中心对肺炎旁胸腔积液和脓胸患儿的治疗演变情况。
我们对2006年12月至2015年12月期间患有肺炎旁胸腔积液、胸腔积液和胸膜脓胸的儿科患者进行了回顾性病例记录审查。通过数字数据库搜索来确定人口统计学数据、转诊医院、放射学和微生物学检查结果。分析住院时间和发病率。
在研究期间,115名患者接受了159次干预。54名儿童仅通过肋间引流(ICD)和尿激酶纤维蛋白溶解术成功治疗。有19例初次电视辅助胸腔镜手术(VATS),12例在初次肋间引流后进行VATS。33名儿童需要开胸手术,比上一时期减少了26%(p=0.009)。中位住院时间为9天(范围2 - 54天)。
肺炎旁胸腔积液可通过肋间引流和胸膜内纤维蛋白溶解剂成功治疗,但一部分患者需要进一步的手术干预。在我们医院,纤维蛋白溶解术和VATS的使用增加,同时开胸手术的需求相应减少。需要开胸手术的患者在超声检查中均患有严重疾病,但超声不能可靠地预测纤维蛋白溶解治疗的失败。
III级。